Circulating tumor DNA (ctDNA) dynamics associate with treatment response and radiological progression-free survival (rPFS): Analyses from a randomized phase II trial in metastatic castration-resistant prostate cancer (mCRPC).
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Institute of Cancer Research, Genentech, Royal Marsden Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Roche
OpenAlex ID: W3029297306
